Hutchmed
Clinical trials sponsored by Hutchmed, explained in plain language.
-
Experimental IDH drug trial halted early
Disease control TerminatedThis early-stage trial tested an experimental drug called HMPL-306 in 46 adults with advanced blood cancers that have a specific genetic change (IDH mutation). The goal was to find a safe dose and see if the drug could shrink or control the cancer. The study was terminated early,…
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated May 26, 2026 10:28 UTC
-
Experimental IDH drug trial halted early
Disease control TerminatedThis early-stage study tested an experimental drug called HMPL-306 in people with advanced solid tumors that have a specific genetic change (IDH mutation). The main goals were to check the drug's safety and find the best dose. The study was terminated early, so results are limite…
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
Experimental lymphoma pill shows early promise but study halted
Disease control TerminatedThis early-stage study tested an oral drug called HMPL-523 in 69 adults with lymphoma that had returned or stopped responding to other treatments. The main goals were to check safety, find the right dose, and see if the drug could shrink tumors. The study was stopped early, so re…
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated May 18, 2026 12:12 UTC